AIM ImmunoTech Inc. — Director's Dealing 2019

Sep 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2019-09-03

Reporting Person: APPELROUTH STEWART (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-03	Common Stock	J	2112	$1.8	Acquired	33652	Direct

Footnotes

F1: Shares issued for 50 percent of Director's Fee for the second half of August, 2019.